Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles Podcast: Investors Know What Not to Do in Emerging Markets. They Keep Doing It Anyway. Julie Segal Kristie Nettles, V.P., Managing Director and Head of Global Insurance and Institutional (North America) Marketing, AllianceBernstein Institutional Investor Q&A: Where Does FX Liquidity Live When Volatility Hits? Sponsored by CME Group